PAR-25-101-Full-Announcement.html

This is a full grant announcement (PAR-25-101) for the NIDA Cutting-Edge Basic Research Awards (CEBRA), a R21 clinical trial optional grant opportunity administered by the Department of Health and Human Services' National Institutes of Health. The grant focuses on innovative research related to substance use disorders (SUDs) under the Drug Use and Addiction Research Programs (CFDA 93.279).

The opportunity is open to a wide range of applicants including higher education institutions, state/local governments, tribal organizations, nonprofits, and small businesses. Research proposals must either develop revolutionary techniques for addiction research or test innovative hypotheses that could transform current understanding of SUDs. The program specifically seeks high-risk, high-impact research projects that are currently underrepresented in NIDA's portfolio. While the file contains the full announcement details, specific funding amounts and key dates are not provided in this excerpt.